A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2001
10/24/2001	EP1147205A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site
10/24/2001	EP1147175A2 Fibres for culturing eukaryotic cells
10/24/2001	EP1147138A1 Hydrophilic ampholytic polymer
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1147115A2 Tricyclic benzodiazepines as vasopressin receptor antagonists
10/24/2001	EP1147112A1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/24/2001	EP1147110A1 Pyrazino(aza)indole derivatives
10/24/2001	EP1147105A1 Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatement of vascular diseases
10/24/2001	EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1147079A2 Beta-phenylalanine derivatives as integrin antagonists
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146898A1 Vaccine-mediated treatment of neurological disorders
10/24/2001	EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001	EP1146891A1 Inhibiting development of microvessels within vascular walls
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146879A1 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
10/24/2001	EP1146875A1 Myt1 kinase inhibitors
10/24/2001	EP1146874A1 Vitronectin receptor antagonist
10/24/2001	EP1146872A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
10/24/2001	EP1146870A1 Antioxidant compositions and methods for companion animals
10/24/2001	EP1146865A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
10/24/2001	EP1146863A1 Lyophilisates with improved reconstitutibility
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001	EP0854721B1 Endothelin receptor antagonists
10/24/2001	EP0660713B1 Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
10/24/2001	EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001	CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001	CN1319095A Imidazole compounds and their use as adenosine deaminase inhibitors
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319014A Use of benzenesulfonyl (thio) ureas for treatment and prophylaxis of dysfunctions of autonomous nervous system and use of benzenesulfonyl(thio) ureas in combination with beta-receptor blockers
10/24/2001	CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001	CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors
10/24/2001	CN1319004A New pharmaceutical formulation
10/24/2001	CN1318393A Allicin health care liquid
10/24/2001	CN1318375A Preparation of coronary heart disease treating medicine powder
10/24/2001	CN1318374A Preparation of Xinnaomaitong injecta for promoting blood circulation
10/24/2001	CN1318372A Application of insulin sensitizing agent in treatment of nephrosis
10/24/2001	CN1318371A New use of flavone
10/24/2001	CN1073557C Vitamin-D amide derivatives
10/24/2001	CN1073436C Method for preparing Gingko leaf extract preparation
10/24/2001	CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist
10/24/2001	CN1073416C New use of caffeic acid and ferulic acid antagonistic endotheliolysin biological effect
10/23/2001	US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma.
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307050 Method of synthesizing flosequinan from 4-fluoroanthranilic acid
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307038 Nucleotide sequences coding fusion protein for use in treatment of oxidative stress
10/23/2001	US6307027 Bradykinin B1 receptor antibodies
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306911 Enzyme inhibitors
10/23/2001	US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306886 Solid polymorph anticoagulants
10/23/2001	US6306878 Pharmaceutical compositions containing hydroximic acid derivatives
10/23/2001	US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
10/23/2001	US6306875 Growth-hormone secretagogues
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306870 N-cinnamoyl derivatives of beta-carboline
10/23/2001	US6306863 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
10/23/2001	US6306861 Thienopyrancecarboxamide derivatives
10/23/2001	US6306854 Chemical compounds
10/23/2001	US6306852 Indole derivatives useful as endothelin receptor antagonists
10/23/2001	US6306849 Selected derivatives of K-252a
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306826 Administering angiotensin ii receptor inhibitor daily after myocardial infarction; reducing dosage
10/23/2001	US6306819 Method for regulating size of vascularized normal tissue
10/23/2001	US6306612 Methods of facilitating vascular growth
10/23/2001	US6306398 Delipidating plant powder by extraction of powder with a solution containing organic solvent; separating powder from organic solvent; extracting delipidated powder with solvent or phosphate buffered saline; separation to obtain retentate
10/23/2001	US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage
10/23/2001	CA2236368C Sublingual and buccal administration of selegiline
10/23/2001	CA2085570C Pyrrolidine derivatives, process for their preparation and pharmaceutical compositions containing them
10/23/2001	CA2079189C (benzocycloalkyl) alkylamines, their preparation process and pharmaceutical compositions containing them
10/23/2001	CA2049368C Treatment of cerebro-vascular disorders
10/23/2001	CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
10/23/2001	CA2035749C Pyrroloazepine derivatives
10/18/2001	WO2001077673A1 Hypotensors
10/18/2001	WO2001077389A2 Genes expressed in foam cell differentiation
10/18/2001	WO2001077378A2 Diagnosis of diseases associated with dna adducts
10/18/2001	WO2001077377A2 Diagnosis of diseases associated with dna replication by assessing dna methylation
10/18/2001	WO2001077376A2 Diagnosis of diseases associated with metastasis
10/18/2001	WO2001077375A2 Diagnosis of diseases associated with gene regulation
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes

1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 1595